Evidence map›Paper›PMID 42495301›Full record

ArticleACS omega2026

"AND Gate" Logic Fluorescence Sensing Platform for Highly Specific Detection of Dual microRNA Biomarkers.

Guoshi Lin, Shichang Rao, Xiaocheng Li, Zhipeng Liang, Aishun Guo, Ruisheng Lin, Zongqing Zheng, Weiping Cai

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Guoshi LinDepartment of Neurosurgery, Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou Municipal Hospital of Fujian Province, Zhangzhou 363000, China.
Shichang RaoCollege of Materials Science and Engineering, Fuzhou University, Fuzhou 350108, China.
Xiaocheng LiDepartment of Neurosurgery, Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou Municipal Hospital of Fujian Province, Zhangzhou 363000, China.
Zhipeng LiangDepartment of Neurosurgery, The Fifth Hospital of Zhangzhou, Zhangzhou 363107, China.
Aishun GuoDepartment of Neurosurgery, Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou Municipal Hospital of Fujian Province, Zhangzhou 363000, China.
Ruisheng LinDepartment of Neurosurgery, Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou Municipal Hospital of Fujian Province, Zhangzhou 363000, China.
Zongqing ZhengDepartment of Neurosurgery, Neurosurgery Research Institute, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China.
Weiping CaiDepartment of Neurosurgery, Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou Municipal Hospital of Fujian Province, Zhangzhou 363000, China.ORCID https://orcid.org/0009-0006-3234-8580

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Early diagnosis of glioma, which is the most common and highly malignant primary tumor of the central nervous system, is highly important for improving patient survival rates. MicroRNAs (miRNAs), such as miR-21 and miR-155, are aberrantly expressed in gliomas and serve as potential early diagnostic biomarkers. In this study, an "AND gate" logic fluorescence sensing platform based on upconversion nanoparticle (UCNP) and mesoporous silica (mSiO

Identifiers

PMID42495301
PMCPMC13393175

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.